Foghorn Therapeutics Inc. (FHTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -25.27M | -22.27M | -18.86M | -21M | -23.97M | -24.52M | -21M | -25.54M | -29.34M | -27.54M | -27.21M | -32.17M |
| Operating CF Margin % | -773.37% | -240.85% | -231.33% | -277.89% | -402.69% | -858.51% | -269.02% | -370.75% | -581.09% | -477.4% | -155.68% | -574.66% |
| Operating CF Growth % | -5.42% | 9.17% | 10.21% | 17.77% | 18.32% | 10.97% | 22.8% | 20.63% | 5.89% | 4.78% | -36.15% | -10.9% |
| Net Income | -19.88M | -21.66M | -15.85M | -17.94M | -18.83M | -19.5M | -19.12M | -22.98M | -25.02M | -24.11M | -14.35M | -29.49M |
| Depreciation & Amortization | 238K | 851K | 900K | 851K | 827K | 761K | 700K | 800K | 835K | 852K | 864K | 2.17M |
| Stock-Based Compensation | 2.38M | 2.24M | 0 | 2.73M | 2.69M | 2.48M | 0 | 0 | 3.22M | 3.05M | 4.09M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 173K | 4.5M | 3.02M | 1.07M | 631K | -141K | 2.65M | 6.3M | 865K | 900K | 673K | 3.74M |
| Working Capital Changes | -8.19M | -8.2M | -6.94M | -7.72M | -9.28M | -8.12M | -5.23M | -9.66M | -9.25M | -8.24M | -18.5M | -8.59M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -990K | 1.05M | -110K | -747K | 284K | 334K | -1.35M | -829K | -629K | -236K | -438K | -171K |
| Cash from Investing | -17.72M | 13.23M | 35.57M | 33.83M | 29.4M | 22.29M | -61.31M | -17.98M | 27.09M | 37.38M | 38.43M | 39.13M |
| Capital Expenditures | 0 | 0 | 0 | -22K | -28K | -479K | -309K | -17K | -101K | -37K | -82K | -469K |
| CapEx % of Revenue | - | - | - | 0.29% | 0.47% | 16.77% | 3.96% | 0.25% | 2% | 0.64% | 0.47% | 8.38% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 1K | 0 |
| Cash from Financing | 49.77M | 581K | 49K | 254K | 139K | 4K | 1.05M | 103.21M | 1.17M | 186K | 1.39M | 103K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 49.77M | 581K | 49K | 254K | 139K | 0 | 1.44M | 103.4M | 0 | 0 | 0 | 103K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 4K | -390K | -195K | 1.17M | 186K | 1.39M | 0 |
| Net Change in Cash | 6.79M | -8.46M | 16.76M | 12.8M | 5.57M | -2.22M | -81.27M | 59.69M | -1.08M | 10.03M | 12.6M | 7.06M |
| Free Cash Flow | -25.27M | -22.27M | -18.86M | -21.02M | -24M | -25M | -21.31M | -25.55M | -29.45M | -27.58M | -27.29M | -32.64M |
| FCF Margin % | -773.37% | -240.85% | -231.33% | -278.18% | -403.16% | -875.28% | -272.98% | -370.99% | -583.09% | -478.04% | -156.15% | -583.03% |
| FCF Growth % | -5.29% | 10.91% | 11.51% | 17.73% | 18.51% | 9.36% | 21.9% | 21.72% | 7.45% | 5.53% | -34.34% | -11.12% |
| FCF per Share | -0.36 | -0.35 | -0.30 | -0.33 | -0.38 | -0.40 | -0.34 | -0.50 | -0.69 | -0.65 | -0.65 | -0.78 |
| FCF Conversion (FCF/Net Income) | 1.27x | 1.03x | 1.19x | 1.17x | 1.27x | 1.26x | 1.10x | 1.11x | 1.17x | 1.14x | 1.90x | 1.09x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 1K | 0 | 4K | 4K | 47K | 0 | 0 | 49K | 865K | 996K | 0 |